Open AccessPerspective: Is It Time to Rename MSC (Mesenchymal Stem Cells/Medicinal Signaling Cells) with a Name that Reflects Their Combined <i> In Vivo </i> Functions and Their <i> In Vitro </i>Abilities?—Possibly “Pluripotent Mesenchymal Regulatory Cells (PMRC)”
Author(s) -
David A. Hart
Publication year - 2021
Publication title -
journal of biomedical science and engineering
Language(s) - English
Resource type - Journals
eISSN - 1937-688X
pISSN - 1937-6871
DOI - 10.4236/jbise.2021.148027
Subject(s) - mesenchymal stem cell , microbiology and biotechnology , in vivo , paracrine signalling , biology , microvesicles , induced pluripotent stem cell , in vitro , regeneration (biology) , chondrogenesis , chemistry , biochemistry , microrna , embryonic stem cell , receptor , gene